Work from the HUGO Pan-Asian Single Nucleotide Polymorphism (SNP) consortium has mapped human genetic diversity in different subpopulations in Asia (Abdulla et al, [@b1]). Now this highlights the question whether disease-SNP associations identified by genome-wide association studies (GWAS) in one subpopulation can be applied to other subpopulations or whether separate GWAS should be considered for different subpopulations because of their different SNP distributions (Haiman & Stram, [@b7]).

DNA methylation is an epigenetic mark in the mammalian genome. 'Epigenetic diversity' encompasses variation in DNA methylation and like 'genetic diversity', 'epigenetic diversity' may also co-vary with phenotype (Feinberg et al, [@b6]). Mechanistically, disease-associated SNPs may be found in DNA regulatory regions where the genetic variation affects cognate binding of transcription factor complexes, effecting on the expression of disease-relevant genes (Harismendy et al, [@b8]). Similarly, variation in the methylation of a DNA regulatory region (either increased or decreased methylation) can also alter the binding of transcription factor complexes and regulate both distal and proximal gene expression (Choy et al, [@b3]; Jones & Takai, [@b9]; Phillips & Corces, [@b12]; Weaver et al, [@b13]). The availability of genome-wide maps of DNA methylation (Choy et al, [@b3]; Down et al, [@b4]; Lister et al, [@b11]) led us to examine whether a relationship exists between DNA methylation and regions of heterogeneous genetic variation.

The Fixation Index (Fst) is a measure of fixation rate of SNP between two subpopulations. SNPs with high Fst are ones with more heterogeneity in a subpopulation compared to another. Using DNA methylation maps that were generated from individuals of European ancestry, we made the interesting discovery that high Fst-SNPs (Duan et al, [@b5]) (*N* = 8751) from European ancestry showed an aggregate methylation density pattern of modulation centred on SNPs compared to flanks of the SNPs ([Fig 1](#fig01){ref-type="fig"}). Methylation maps from Europeans showed density modulation only at sites of European high Fst-SNPs (i.e. high Fst-SNPs for European *vs*. African + European *vs*. Asian), but not sites of Asian or African high Fst-SNPs (i.e. high Fst-SNPs for Asian *vs*. European; or African *vs*. European, [Fig 1](#fig01){ref-type="fig"}). Similarly aggregate methylation density modulation was also absent in a negative control set of randomly selected SNPs (*N* = 8000). On the basis that increased DNA methylation may be a means of regulating transcription factor complex binding and therefore mark genomic regions that are important to control by methylation (Choy et al, [@b3]; Jones & Takai, [@b9]), our findings support the notion that sites of heterogeneous genetic variation in one subpopulation are functionally relevant to the corresponding subpopulation, but sites of heterogeneous genetic variation of a different subpopulation, are not.
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Methylation maps from hearts (blue) and sperm (green) from Europeans were used and aggregate methylation density was plotted against sites −1000 to +1000 bp of European, Asian, African high-Fst-SNPs, and random SNPs. European methylation density showed a statistically significant pattern of modulation only in European high Fst-SNPs but not high Fst-SNPs of other subpopulations (one-way ANOVA for methylation density at red and yellow bars, *p* \< 0.05 for hearts and *p* \< 0.001 for sperm). Aggregate methylation density (BATMAN score) was generated and plotted using algorithms previously described (Choy et al, [@b3]; Down et al, [@b4]). MeDIP-seq (Methylated DNA-immunoprecipitation followed by high-throughput sequencing) data were generated from four human hearts and spermatozoa and analyzed using a Bayesian deconvolution strategy (BATMAN score) (Choy et al, [@b3]; Down et al, [@b4]). BATMAN scores from four healthy human hearts were averaged using Perl script written by HGG and MKC as described in Choy et al, ([@b3]). Average plots of methylation densities were calculated using an algorithm found in a public resource (Kolasinska-Zwierz et al, [@b10]).](emmm0003-0573-f1){#fig01}

This is consistent with the need to consider subpopulation differences in genetic variation when studying disease-SNP association. By extension, we propose that the epigenomes of subpopulations should also be considered as the International Human Epigenome Consortium gears up to generate 1000 reference epigenomes (Beck, [@b2]). Subpopulation differences will be important when drawing conclusions from associations between disease and the human variome.
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